Chronic rejection and late renal allograft dysfunction

Pediatric Nephrology

Volumn 10, Issue 2, 1996, Pages 221-229

  Laine, Jarmo ^a   Holmberg, Christer ^a   Häyry, Pekka ^b,c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Chronic rejection; Transplantation

Indexed keywords

CYTOKINE; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT;

CELL PROLIFERATION; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE;

EID: 0030009392     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00862088     Document Type: Review

References (83)

1. Laine J, Holmberg C, Salmela K, Jalanko H, Sairanen H, Peltola K, Rönnholm K, Eklund B, Wikström S, Leijala M (1994) Renal transplantation in children with emphasis on young patients. Pediatr Nephrol 8:313-319
2. Hayry P, Mennander A, Yilmaz S, Ustinov J, Räisänen A, Miettinen A, Lautenschlager I, Lemstr'm K, Bruggeman CA, Paavonen T (1992) Towards understanding the pathophysiology of chronic rejection. Clin Invest 70:780-790
3. Isoniemi H, Kyllönen L, Eklund B, Hockerstedt K, Salmela K, Willebrand E v, Ahonen J (1995) Acute rejection under triple immunosuppressive therapy does not increase the risk of late first renal cadaveric allograft loss. Transplant Proc (in press)
4. First MR, Vaidya PN, Maryniak RK, Weiss MA, Munda R, Fidler JP, Penn I, Alexander JW (1984) Proteinuria following transplantation - correlation with histopathology and outcome. Transplantation 38:607-612
5. Vathsala A, Verani R, Schoenberg L, Lewis RM, Van Buren CT, Kerman RH, Kahan BD (1990) Proteinuria in cyclosporine-treated renal transplant recipients. Transplantation 49:35-41
6. Maryniak RK, First MR, Weiss MA (1985) Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 27:799-806
7. Solez K, Axalsen RA, Benediktsson H (1993) International standardization of criteria for the diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44:411-422
8. Paul LC, Fellström B (1992) Chronic vascular rejection of the heart and the kidney-have rational treatment options emerged. Transplantation 53:1169-1179
9. Croker BP, Salomon DR (1989) Pathology of renal allograft. In: Tisher CC, Brenner BM (eds) Renal pathology, vol 2., Lippincott, Philadelphia pp 1518-1554
10. Demetris AJ, Zerbe T, Banner B (1989) Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc 21:3667-3669
11. Russell PS, Chase CM, Winn HJ, Colom RB (1994) Coronary atherosclerosis in transplanted mouse hearts. J Immunol 152: 5135-5141
12. De Heer E, Davidoff A, Van Der Wal A, Van Geest M, Paul LC (1994) Chronic renal allograft rejection in the rat. Transplantation induced antibodies against basement membrane antigens. Lab Invest 70:494-502
13. Duijvestijn AM, Van Breda Vriesman PJC (1991) Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation. Transplantation 52:195-202
14. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH (1992) Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 339:1566-1570
15. Suciu-Foca N, Reed E, D'Agati VD, Ho E, Cohen DJ, Benvenisty A, McCabe R, King D, Hardt M (1991) Soluble HLA-antigens, anti-HLA antibodies, and anti-idiotypic antibodies in circulation of renal transplant recipients. Transplantation 51: 593-601
16. Hruban RH, Beschomer WE, Baumgartner WA, Augustine SM, Ren H, Reitz BA, Hutchins GM (1990) Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 137:871-882
17. Salomon RN, Hughes C, Schoen FJ, Payne D, Pober JS, Libby P (1991) Human coronary transplantation-associated arteriosclerosis. Am J Pathol 138:791-798
18. Doukas J, Pober JS (1990) Lymphocyte-mediated activation of cultured endothelial cells (EC): CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression. J Immunol 145:1088-1098
19. Häyry P, Räisänen A, Ustinov J, Mennander A, Paavonen T (1993) Somatostatin analogue Lantreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J 7:1055-1060
20. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS (1993) Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752-757
21. Matas AJ, Gillingham KJ, Payne WD, Najarian JS (1994) The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57:857-859
22. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DER, Gores PF, Gruessner RWG, Najarian JS (1993) Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 55:993-995
23. Ferguson RM, Henry ML, Elkhammas EA, Tesi RJ (1992) Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival (abstract). Abstracts of the 18th annual meeting of the American Society of Transplant Surgeons, Chicago.
24. Yilmaz S, Häyry P (1994) The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 56:1153-1156
25. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW (1992) Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 327:834-839
26. Modena F, Hostetter T, Salahudeen A, Najarian J, Matas A, Rosenberg M (1991) Progression of kidney disease in chronic renal transplant rejection. Transplantation 52:239-244
27. Tullius SG, Hancock WW, Heemann U, Azuma H, Tilney NL (1994) Reversibility of chronic renal allograft rejection. Transplantation 58:93-99
28. Kuo P, Monaco AP (1993) Chronic rejection and suboptimal immunosuppression. Transplant Proc 25:2082-2084
29. Laine J, Krogerus L, Jalanko H, Ronnholm K, Holmberg C (1995) Renal allograft histology and correlation with function in children on triple therapy. Nephrol Dial Transplant 10:95-102
30. Tullius SG, Heemann U, Hancock WW, Azuma H, Tilney NL (1994) Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 220:425-435
31. Glassock RJ, Feldman D, Reynolds EG, Dammin G, Merrill J (1968) Human renal isografts: a clinical and pathological analysis. Medicine (Baltimore) 47:411-454
32. Halloran P, Aprile M, Farewell V, Ludvin D, Smith E, Tsai S, Bear R, Cole E, Fenton S, Cattran D (1988) Early function as the principal correlate of graft survival. Transplantation 46:223-228
33. Barry J, Shively N, Hubert B, Hefty T, Norman D, Bennett W (1988) Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants. Transplantation 45:346-348
34. Van Es A, Hermans J, Van Bockel JH, Persijn G, Hooff J van, Graeff J de (1983) Effect of warm ischemia time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes. Transplantation 36:255-258
35. Yilmaz S, Paavonen T, Häyry P (1992) Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation 53:823-827
36. Land W, Schneeberger H, Schleibner S, Illner W-D, Abendroth D, Rutili G, Arfors KE, Messmer K (1994) The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57.211-217
37. Goes N, Urmson J, Ramassar V, Halloren P (1995) Recombinant insulin-like growth factor-1 abrogates cytokine and MHC induction in response to acute tubular necrosis (abstract). Abstracts of the 14th Annual Meeting of American Society of Transplant Physicians
38. Troppmann C, Gillingham K, Benedetti E, Almond P, Groessner R, Najarian J, Matas A (1995) Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation. Transplantation 59:962-968
39. Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652
40. Brenner BM, Cohen RA, Milford EL (1992) In renal transplantation, one size may not fit all. J Am Soc Nephrol 3:162-169
41. Terasaki PI, Koyama H, Cecka JM, Gjertson DW (1994) The hyperfiltration hypothesis in human renal transplantation. Transplantation 57:1450-1454
42. Najarian JS, Chavers BM, McHugh LE, Matas AJ (1992) Twenty years or more of follow-up of living kidney donors. Lancet 340:807-810
43. Hostetter T, Olson J, Rennke H, Venchatalam M, Brenner B (1981) Hyperfiltration in remainig nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85-F93
44. Kingma I, Chea R, Davidoff A, Benediktsson H, Paul L (1993) Glomerular capillary pressures in long-surviving rat renal allografts. Transplantation 56:53-60
45. Meyer TW, Scholey JW, Brenner B (1991) Nephron adaptation to renal injury. In: Brenner B, Rector F (eds) The kidney. Philadelphia, Saunders, pp 1871-1908
46. Daniels B, Hostetter T (1990) Adverse effects of growth in the renal microcirculation. Am J Physiol 258:F1409-F1416
47. Miller P, Scholey J, Rennke H, Meyer T (1990) Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin Invest 85:1119-1126
48. Remuzzi G, Bertani T (1990) Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38:384-394
49. Cortes P, Riser B, Xhao X, Narins R (1994) Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int 45:S11-S16
50. Nath KA, Croatt A, Hostetter T (1990) Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol F1354-F1362
51. Grattan MY, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566
52. Koskinen P, Lemström K, Bruggeman C, Lamenschlager I, Häyry P (1994) Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. Am J Pathol 144:41-50
53. Smiley M, Mar E, Huang E (1988) Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J Med Virol 25:213-226
54. Tumilowicz J, Gawlik M, Bowell P, Trentin J (1985) Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 56:839-845
55. Fujinami R, Nelson J, Walker L, Oldstone M (1988) Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol 62:100-105
56. Beck S, Barrel B (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 331:269-272
57. Speir E, Modali R, Huang E-S, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394
58. Rubin R, Tolkoff-Rubin N, Oliver D, Rota T, Hamilton J, Betts R, Pass R, Hillis W (1985) Multicenter sero-epidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40:243-249
59. Gagnadoux MF, Niaudet P, Broyer M (1993) Non-immunological risk factors in paediatric renal transplantation. Pediatr Nephrol 7:89-95
60. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Wiederhold V, Stinson EB (1987) Clinical and laboratory correlation of accelerated coronary artery disease in the cardiac transplant patient. Circulation 76:V56-V61
61. Adams DH, Karnovsky MJ (1989) Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts. Transplant Proc 21:437-439
62. Mennander A, Tikkanen MJ, Räisänen-Sokolowski A, Paavonen T, Ustinov J, Häyry P (1993) Effect of hypercholesterolemia in allograft arteriolosclerosis. J Heart Lung Transplant 12:123-131
63. Räisänen-Sokolowski A, Tilly-Kiesi M, Ustinov J, Mennander A, Paavonen T, Tikkanen M, Häyry P (1994) Hyperlipidemia accelerates allograft arteriolosclerosis (chronic rejection) in the rat. Arterioscler Thromb 14:2032-2042
64. Isoniemi H, Nurminen M, Tikkanen MJ, Von Willebrand E, Krogerus L, Ahonen J, Eklund B, Höckerstedt K, Salmela K, Häyry P (1994) Risk factors predicting chronic rejection of renal allografts. Transplantation 57:68-72
65. Knight RJ, Kerman RH, Welsh M, Golden D, Schoenberg L, Van Buren CT, Lewis RM, Kahan BD (1991) Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy. Transplantation 51:355-359
66. Kasiske B, Kalil R, Lee H, Rao K (1991) Histopathologic findings associated with chronic, progressive decrease in renal allograft function. Kidney Int 40:514-524
67. Bresticker M, Nelson J, Huang C, Wolf J, Anderson B (1991) Plasma renin activity in renal transplant recipients with hypertension. Am J Hypertens 4:623-626
68. Ritz E, Orth S, Weinreich T, Wagner J (1994) Systemic hypertension versus intraglomerular hypertension in progression. Kidney Int 45:438-442
69. Mason J (1990) The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol 4: 554-574
70. McNally PG, Feehally J (1992) Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant 7:791-804
71. Garcia D, Rennke G, Brenner B, Anderson S (1987) Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J Clin Invest 80:867-874
72. Ettenger R, Rosenthal J, Marik J, Malekzadeh M, Forsythe S, Kamil E, Salusky I, Fine R (1991) Improved cadaveric renal transplant outcome in children. Pediatr Nephrol 5:137-142
73. Laine J, Fyhrquist F, Holmberg C (1994) Effect of donor source on renal graft function in children on triple immunosuppression. Nephrol Dial Transplant 9:1468-1473
74. European mycophenolate mofetil study group (1995) Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325.
75. Foegh M, Khiribadi B, Chambers E, Amamoo S, Ramwell P (1989) Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide. Atherosclerosis 78:229-236
76. Meiser B, Mair H, Scheldt W v, Kur F, Detter C, Uberfuhr P, Kreuzer E, Foegh M, Reichart B (1995) Significant reduction of graft vessel disease after heart transplantation by short-term angiopeptin treatment (abstract). Abstracts of the 14th Annual Meeting of American Society of Transplant Physicians
77. Clowes A, Clowes M (1989) Inhibition of smooth muscle cell proliferation by heparin molecules. Transplant Proc 21:3700-3701
78. Allison A, Eugui E, Sollinger H (1993) Mycophenolate mofetil (RS-61443): mechanisms of action and effects in transplantation. Transplant Rev 7:129-139
79. Belitsky P, Gulanikar A, He G, Gupta R (1993) The effect of immunosuppression on chronic rejection in the rat aortic allograft model. Transplant Proc 25:935
80. Salahudeen A, Hostetter T, Raatz S, Rosenberg M (1992) Effects of dietary protein in patients with chronic renal transplant rejection. Kidney Int 41:183-190
81. Kootte AMM, Hart-Eerdmans 't , Paul LC (1988) Cyclosporine therapy or dietary protein manipulation in chronic renal allograft therapy. Transplant Proc 20:821-826
82. Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, Baumgartner H (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-188
83. Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G (1993) Calcium channel blockers protect transplant patients from cyclosporine-induced daily hypoperfusion. Kidney Int 43:706-711